Alexander Roberts

(Former)

ORCID: 0000-0001-6846-3691
View graph of relations

Most downloaded publications

Novel mechanism of modulation at a ligand-gated ion channel; action of 5-Cl-indole at the 5-HT3A Receptor
Gillian Grafton, Alexander Roberts, Alison Cooper & Nicholas Barnes, Dec 2016, In: British Journal of Pharmacology. 173, 24, p. 3467-3479 13 p.

Research output: Contribution to journal › Article › peer-review

132 downloads
CSTI-300 (SMP-100); a novel 5-HT3 receptor partial agonist with potential to treat patients with irritable bowel syndrome or carcinoid syndrome
Alexander Roberts, Gillian Grafton, Andy Powell, Kristian Brock, Alison Cooper, Omar Qureshi, Zania Stamataki & Nicholas Barnes, 1 Apr 2020, In: Journal of Pharmacology and Experimental Therapeutics. 373, 1, p. 122-134 13 p.

Research output: Contribution to journal › Article › peer-review

50 downloads
Ex vivo modelling of PD-1/PD-L1 immune checkpoint blockade under acute, chronic, and exhaustion-like conditions of T-cell stimulation
Alexander Roberts, Tina Tang, Chiara Pallini, Graham Wallace, Alison Cooper, Aaron Scott, David Thickett, Sebastian Lugg, Thomas Pinkney, Graham Taylor, Kristian Brock, Zania Stamataki, John Curnow, John Gordon, Omar Qureshi, Nicholas Barnes & 7 others, , 17 Feb 2021, In: Scientific Reports. 11, 4030.

Research output: Contribution to journal › Article › peer-review

6 downloads

Recent publications

Ex vivo modelling of PD-1/PD-L1 immune checkpoint blockade under acute, chronic, and exhaustion-like conditions of T-cell stimulation
Alexander Roberts, Tina Tang, Chiara Pallini, Graham Wallace, Alison Cooper, Aaron Scott, David Thickett, Sebastian Lugg, Thomas Pinkney, Graham Taylor, Kristian Brock, Zania Stamataki, John Curnow, John Gordon, Omar Qureshi, Nicholas Barnes & 7 others, , 17 Feb 2021, In: Scientific Reports. 11, 4030.

Research output: Contribution to journal › Article › peer-review

Deconstructing depression and negative symptoms of schizophrenia; differential and longitudinal immune correlates, and response to minocycline treatment
5 Nov 2020, In: Brain, Behaviour, and Immunity. 0, p. 1-7 7 p.

Research output: Contribution to journal › Article › peer-review

CSTI-300 (SMP-100); a novel 5-HT3 receptor partial agonist with potential to treat patients with irritable bowel syndrome or carcinoid syndrome
Alexander Roberts, Gillian Grafton, Andy Powell, Kristian Brock, Alison Cooper, Omar Qureshi, Zania Stamataki & Nicholas Barnes, 1 Apr 2020, In: Journal of Pharmacology and Experimental Therapeutics. 373, 1, p. 122-134 13 p.

Research output: Contribution to journal › Article › peer-review

View all (4)